France Pharmaceuticals & Healthcare Report Q3 2018

France Pharmaceuticals & Healthcare Report Q3 2018

BMI View:

France’s pharmaceutical and healthcare spending will remain on a positive growth trajectory over a multi-year horizon,creating renewed opportunities for drugmakers and healthcare service providers. Rising demand for healthcare due to an ageingpopulation will underpin this trend. That said, the need to create savings will translate into government cost-control measures,including targeting drug spending as a means to keep costs in line with spending growth targets. Meanwhile, labour marketreform and government incentives for innovation will improve the investment environment in several sectors, including biomedicalindustries, slowly reversing the loss of competitiveness of recent years.

BMI Industry View
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Western Europe Pharmaceuticals: Large Market Sizes Boost Attractiveness
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Merck & Co
Demographic Forecast
Demographic Outlook
Pharmaceuticals & Healthcare Glossary

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook